6 drug companies could face steep fines for violating 340B law healthcaredive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcaredive.com Daily Mail and Mail on Sunday newspapers.
Lilly, Novartis, other pharmas could face fines for violating 340B law biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.
Takeaways for Entities from the 340B in 2021 Webinar natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
Eli Lilly Prevails In Blocking Immediate Implementation Of HHS's 340B Drug Discount Rule Involving Dispute Resolution Between Manufacturers And Covered Entities - Food, Drugs, Healthcare, Life Sciences mondaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mondaq.com Daily Mail and Mail on Sunday newspapers.
To print this article, all you need is to be registered or login on Mondaq.com.
On December 10, 2020, the U.S. Department of Health and Human
Services ( HHS ), Health Resources and Services
Administration ( HRSA ) issued a long-anticipated
regulation of interest to drug makers and providers: the 340B Drug
Pricing Program Alternative Dispute Resolution Final Rule
( ADR Final Rule ).
1 The ADR Final Rule
establishes an alternative dispute resolution ( ADR )
process that offers manufacturers and 340B covered
entities a means of negotiating certain disputes in a more
formal setting without resorting to litigation or private
arbitration. In the ADR Final Rule, HRSA notes that its intention